Susquehanna International Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-16,800
Closed -$60K 11205
2019
Q1
$60K Buy
+16,800
New +$72.8K ﹤0.01% 8430
2018
Q3
Sell
-25,000
Closed -$106K 10754
2018
Q2
$106K Buy
25,000
+9,200
+58% +$46.4K ﹤0.01% 9018
2018
Q1
$70K Buy
+15,800
New +$70.5K ﹤0.01% 8847
2017
Q3
Sell
-37,800
Closed -$273K 10052
2017
Q2
$273K Sell
37,800
-701,400
-95% -$4.31M ﹤0.01% 7744
2017
Q1
$3.92M Buy
739,200
+720,600
+3,874% +$4.87M ﹤0.01% 2635
2016
Q4
$134K Sell
18,600
-4,400
-19% -$35.6K ﹤0.01% 8930
2016
Q3
$215K Buy
+23,000
New +$191K ﹤0.01% 7474

Other funds holding PETX

Susquehanna International Group's PETX Position: Q3 2019 in Review

Susquehanna International Group sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 18,949 shares — an estimated $98K sold.

Susquehanna International Group first reported a position in PETX in Q4 2016 and held it in 6 quarters. The position peaked at $3.31M in Q1 2017. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Susquehanna International Group reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Susquehanna International Group sold 18,949 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $98K.
  • Susquehanna International Group first reported a position in Aratana Therapeutics, Inc. in Q4 2016 and held it in 6 quarters.
  • Susquehanna International Group's Aratana Therapeutics, Inc. position peaked at $3.31M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.